How Jain was paid
$6.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|
| Vivek JainChairman of the Board and Chief Executive Officer | $775,000 | $4,500,023 | $1,162,500 | $14,519 | $6,452,042 |
| Brian BonnellChief Financial Officer | $475,000 | $3,000,110 | $427,500 | — | $3,902,610 |
| Christian VoigtlanderChief Operating Officer | $500,000 | $3,000,110 | $450,000 | — | $3,950,110 |
| Daniel WoolsonCorporate Vice President, General Manager - Infusion Systems | $395,192 | $1,350,135 | $360,000 | $11,500 | $2,116,827 |
| Virginia SanzoneCorporate Vice President, General Counsel | $430,000 | $2,000,073 | $387,000 | — | $2,817,073 |
What changed and why
- 86%Approximately 86 percent of executive compensation consists of variable pay.
- Base salaries remained unchanged since 2022 except for a role-related adjustment.
- 100%Long-term equity is tied 100 percent to financial and individual goals.
- $403.8MAdjusted EBITDA grew 9.0 percent to $403.8 million in 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.